Current through Bulletin No. 2024-21, November 1, 2024
Section R414-60B-7 - Clinical and Cost-Related FactorsThe P& T Committee shall base its determinations on the following factors as established by the DURB:
(1) If clinical and therapeutic considerations are substantially equal, then the P& T Committee shall recommend to DMHF that it consider only cost.(2) In making its recommendations to DMHF, the P& T Committee may also consider whether the clinical, therapeutic effects, and medical necessity requirements justify the cost differential between drugs within a therapeutic class.Utah Admin. Code R414-60B-7
Amended by Utah State Bulletin Number 2018-14, effective 6/27/2018